Skip to content
Open access

Immune evasion in classical swine fever: Viral modulation of antigen-presentation pathways

Jul 2026 · Asian Pacific Journal of Tropical Biomedicine · Vol 16, pp. 330-341 · 0 citations · 68 references

TL;DR

Understanding how CSFV manipulates antigen-presentation pathways provides crucial insights for the design of next-generation vaccines and therapeutic strategies capable of restoring robust antiviral immunity.

Abstract

Classical swine fever remains a major threat to global pig production systems, despite decades of sustained control endeavours. Its causative agent classical swine fever virus (CSFV) employs a highly coordinated set of immune evasion mechanisms to weaken host antiviral defences and permit extensive viral replication. A central focus of this strategy is the antigen-presentation machinery, where CSFV disrupts both major histocompatibility complex class (MHC)-I and MHC-II pathways in macrophages and dendritic cells, which are its primary immune cell reservoirs. By suppressing interferon signaling, dysregulating NF-kB activation, and impairing the maturation of antigen-presenting cells, CSFV compromises peptide processing, co-stimulatory signaling, and T-cell priming. These defects propagate through the adaptive immune system, leading to delayed cytotoxic responses, inadequate CD4 + T-cell help, and impaired humoral immunity. CSFV simultaneously reshapes macrophage polarization, drives profound dendritic cell dysfunction, induces lymphoid apoptosis, and modulates γδ T-cell activity in a manner that correlates with viral virulence. In addition, viral remodeling of intracellular organelles further limits antigen presentation and exacerbates immunopathology. Together, these interconnected mechanisms create a permissive cellular environment that facilitates viral persistence and amplifies disease severity. Understanding how CSFV manipulates antigen-presentation pathways provides crucial insights for the design of next-generation vaccines and therapeutic strategies capable of restoring robust antiviral immunity.

Read PDF

Similar papers

Review Open access Sep 2026

Hantavirus: biology, immune responses, and pathogenesis

This review synthesizes the recent research on hantavirus biology, cellular entry mechanisms, and epidemiological characteristics, and highlights that viral immune evasion and subsequent uncontrolled host immune responses act as the core pathogenic drivers.

Yu-Fang Shi, Mauro Piacentini, A. Zumla et al. · 0 citations
Open access Sep 2026

Innate immune activation profiles are associated with polarization of the T cell response to recombinant arenaviral vectors

Despite their shared origins within the arenavirus family, HB- 201 and HB-202 demonstrate distinct differences in early host-virus interaction, potentially resulting in shaping unique T cell responses.

Sarah Szaffich, Valentin Just, Natalija Cvetkovic et al. · 0 citations
Review Open access Sep 2026

Immune Evasion by Neurotropic Viruses: Molecular Strategies, Cellular Targets, and Consequences for CNS Infection

This review examines the diverse yet convergent immune evasion strategies employed by major neurotropic RNA and DNA viruses, including herpes simplex virus, varicella-zoster virus, cytomegalovirus, rabies virus, rabies virus, flaviviruses, alphaviruses, enteroviruses, and JC virus.

Antonios Mouzakis, Vasileios Petrakis, K. Chlichlia · 0 citations
Review Open access Aug 2026

Pathogenicity and virulence of PRRSV: From regulated cell death reprogramming landscape and immune subversion to precision vaccinology

This framework explores regulated cell death pathways as a basis for identifying diagnostic biomarkers and developing precision vaccines for PRRSV and assess emerging intervention strategies, including consensus antigen design, rational attenuation, and nonreplicating platforms such as mRNA and protein nanoparticles.

Shi-Nuo Cao, Mo Zhou, Zhi Wu et al. · 0 citations
Review Open access Sep 2026

Zika virus and host innate immunity: mechanisms of activation and evasion

This Review summarizes current knowledge of how the innate immune system recognizes ZIKV and how the virus counteracts these responses, while highlighting unresolved questions and potential therapeutic targets.

Dan-Yu Qian, Yu-Lei Guo, Ai-Xin Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.